Avivir, a Russian company, has been granted a registration certificate for its pain relieving, Migrenol PM. The drug will once again be available for distribution in Russia starting in August 2023.
In the year 2021, Avivir procured a set of pharmaceuticals named Migrenol from Four Ventures Enterprises, an authorized American. The Migrenol brand encompasses three distinct products: Migrenol, Migrenol PM, and Migrenol Extra.
“Migrenol PM” combines pain-reliever, paracetamol, with the effective antihistamine – diphenhydramine. This medication is recommended for relieving mild to moderate pain. This medication effectively alleviates various types of pain, including headache, toothache, sinusitis, cough, myalgia, arthralgia, dysmenorrhea, and pain that disrupts sleep.
